Mer­ck KGaA in talks to sell its biosim­i­lars R&D ops as shake­out looms

The biosim­i­lars busi­ness is just get­ting es­tab­lished, but the shake­out among a group of high-pow­ered ri­vals is al­ready tak­ing shape.

Mer­ck KGaA CEO Ste­fan Os­chmann …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER